NCT07469306 2026-03-13Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal CancerFujian Cancer HospitalPhase 2 Not yet recruiting130 enrolled
NCT07363512 2026-01-23Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor ThrombusHenan Cancer HospitalPhase 2 Not yet recruiting27 enrolled